Abstract:Glycine supplementation has been reported to enhance white-fat loss and improve sensitivity to insulin in animals with obesity or type 2 diabetes. However, the underlying mechanisms responsible for the beneficial effects of glycine remain largely unknown. The purpose of this study was to test the hypothesis that glycine regulates adipocyte differentiation, adipogenesis, and lipolysis, therefore, contributing to white-fat reduction. 3T3-L1 pre-adipocytes were induced to differentiate into adipocytes in the presence of glycine (0, 0.25, 1.0, and 2.0 mmol/L) or resveratrol (50 or 100 μmol/L, served as a positive control) during the differentiation process. Hela and HepG2 cells cultured with oleic acid to induce lipid accumulation in the presence of glycine (0, 1.0, and 2.0 mmol/L) or 10 μmol/L isoproterenol (served as a positive control) for 24 h. Intracellular lipid accumulation, intracellular triglycerides, lipid droplets’ diameters of mature adipocytes, mRNA, and protein levels of genes involved in the adipogenesis and lipolysis were analyzed. Isobutylxanthine–dexamethasone–insulin (MDI)-induced adipogenesis in 3T3-L1 cells were blocked by resveratrol, but not by glycine, as shown by decreased lipid contents, reduced diameters of lipid droplets, decreased protein abundances for peroxisome proliferator-activated receptor γ (PPARγ), CCAAT-enhancer-binding protein α (C/EBPα), as well as increased protein abundance of peroxisome proliferator-activated receptor coactivator-1α (PGC-1α), critical transcriptional factors that regulates adipogenesis. However, the mRNA levels of adiponectin and interleukin-10 (IL-10), two adipose-derived adipocytokines with anti-inflammatory effects, were greatly enhanced (P < 0.05) by 2 mmol/L glycine. Compared with non-treated controls, 10 μmol/L isoproterenol significantly decreased (P < 0.05) the intracellular lipid and triglyceride contents induced by oleic acid in Hela and HepG2 cells. mRNA level of fatty acid synthase (FASN), a gene involved in fatty acid synthesis, was significantly reduced (P < 0.05), while that for ATGL (adipose triglyceride lipase) and HSL (hormone-sensitive lipase), genes involved in lipolysis were significantly enhanced (P < 0.05) by isoproterenol. However, oleic acid induced the accumulation of intracellular triglyceride and lipid contents were not affected by glycine. In conclusion, glycine exposure enhanced the mRNA levels of adipose-derived adiponectin and IL-10 without affecting adipogenesis and lipolysis in 3T3-L1 adipocytes. These findings provide a possible explanation for the anti-obesity and anti-diabetic effects of glycine that were previously reported in animal models. More studies are needed to uncover the underlying mechanisms responsible for this regulatory effect of glycine on anti-inflammatory adipocytokines expression in both in vitro and in vivo models.

Glycine Increases Glyoxalase‐1 Function by Promoting Nuclear Factor Erythroid 2‐related Factor 2 Translocation into the Nucleus of Kidney Cells of Streptozotocin‐induced Diabetic Rats

Glycine Mitigates Renal Oxidative Stress by Suppressing Nox4 Expression in Rats with Streptozotocin-Induced Diabetes.

Glycine Suppresses AGE/RAGE Signaling Pathway and Subsequent Oxidative Stress by Restoring Glo1 Function in the Aorta of Diabetic Rats and in HUVECs

Glycine Transporter-1 and Glycine Receptor Mediate the Antioxidant Effect of Glycine in Diabetic Rat Islets and INS-1 Cells

Protective effect of glycine against renal ischemia-reperfusion injury and its influence on iNOS expression in rats

Glycine alleviated oxidative stress injury via upregulating caveolin-3/endothelial nitric oxide synthase signal in the myocardium of diabetic rats

Glycine reduced renal lesions caused by AGEs in STZ-induced diabetic rats

Enhancement of Glyoxalase 1, a Polyfunctional Defense Enzyme, by Quercetin in the Brain in Streptozotocin-Induced Diabetic Rats.

Effects of Glycine on Hepatic IGF-I Expression Regulation and the Underlying Signaling Pathways

Renal Ischemia/reperfusion Injury in Rats is Attenuated by a Synthetic Glycine Derivative.

Glycine Protects H9C2 Cardiomyocytes from High Glucose- and Hypoxia/Reoxygenation-Induced Injury Via Inhibiting PKCβ2 Activation and Improving Mitochondrial Quality

Harnessing the benefits of glycine supplementation for improved pancreatic microcirculation in type 1 diabetes mellitus

Glycine Enhances Expression of Adiponectin and IL-10 in 3T3-L1 Adipocytes Without Affecting Adipogenesis and Lipolysis

Effect of Glycine on the Expression of Peroxisome Proliferator-Activated Receptor Α in the Rat Nonalcoholic Fatty Liver

Activation of Nrf2/HO-1 Pathway by Glycogen Synthase Kinase-3β Inhibition Attenuates Renal Ischemia/Reperfusion Injury in Diabetic Rats

Effect of Reduced Glutathione on Nonenzymatic Glycosylation in Kidney of Streptozotocin-Induced Diabetic Rats.

Glycine stimulates protein synthesis and inhibits oxidative stress in pig small intestinal epithelial cells.

Glycine Exhibits Neuroprotective Effects in Ischemic Stroke in Rats through the Inhibition of M1 Microglial Polarization via the NF-κB p65/Hif-1α Signaling Pathway

Galangin Attenuates Liver Injury, Oxidative Stress and Inflammation, and Upregulates Nrf2/HO-1 Signaling in Streptozotocin-Induced Diabetic Rats

Overexpression of Glyoxalase 1 Attenuates Methylglyoxal‐induced Peritoneal Injury with Suppression of Epithelial Mesenchymal Transition Pathway and Neovascularization in Wistar Rats

Improvement Of Ginkgolide B On Diabetic Nephropathy In Streptozotocin (Stz)-Induced Rats